Navigation Links
Vaccine-producing 'plant-factories'

A research team at the Consejo Superior de Investigaciones Científicas (CSIC) has discovered a new route for the transport of proteins in plant cells, a discovery that will enable the biotechnological design of plant factories. Amongst other applications, these can be used to produce oral vaccines which, upon being ingested, will be able to immunise against diseases. Moreover, this discovery opens the door to the design of protein-manufacturing plants of great interest therapeutically and in the development of vaccine antigens.

This discovery, published in the latest issue of The Plant Cell, contributes, moreover, to refuting one of the current scientific dogmas regarding the mechanisms of protein transportation in plant cells.

The research was carried out by a team from the Institute of Agrobiotechnology and Natural Resources (a centre jointly run by the CSIC, the Public University of Navarre and the Government of Navarre), made up of Javier Pozueta, Francisco José Muñoz and Edurne Baroja. These scientists have been aided by a research team from Niigata University (Japan).

Specifically, the study describes a new route for the traffic of proteins from the reticular/Golgi system where there are glycosylates, towards the chloroplasts of the plant cell. Some of these glycosylated recombinant proteins have significant antigenic power of great pharmaceutical interest.

Conventional biotechnological methods enable the cells to accumulate very limited quantities of glycosylate recombinant proteins. The chloroplast is a cell organ with great capacity for storing proteins. However, it is incapable of producing glycosylate proteins.

The newly discovered route connects the cell organ where the proteins are glycosylated, the reticulum, with the chloroplasts. This discovery signifies the first step in the development of plants and algae that accumulate in their chloroplasts large amounts of glycosylate recombinant proteins with sig nificant antigenic power.

By chance

The new route discovered by the CSIC team refutes one of the dogmas regarding this type of protein. Nevertheless, Pozueta reveals that the starting point for this research was a chance discovery. The team had been investigating the metabolism of starch, a substance that is generated in the chloroplast, when they came across an unexpected type of protein for this type of cell organ.

They found that these proteins resisted high temperatures and withstood extreme conditions, characteristics of glycosylate proteins. The discovery was unexpected because the literature written to date does not contemplate the presence of this type of protein in the chloroplast.

Once the presence of this type of protein in the chloroplast was ascertained, the scientists asked themselves if it were the cell organ itself that was glycosylating. This focus gave rise to finding a new route of traffic between the reticulum and the chloroplast. Up to now it has been argued that the endoplasmic reticulum was connected to other parts of the cell such as the Golgi apparatus and the plasmatic membrane, etcetera, but not to the chloroplast.
'"/>

Source:Elhuyar Fundazioa


Related biology news :

1. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
2. Low level of extinction during ice age linked to adaptability
3. Improved statistical tools reveal many linked loci
4. Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels
5. Attacks of King George IIIs madness linked to key metabolism molecule
6. Gene controlling circadian rhythms linked to drug addiction
7. Physical and functional interaction of key cell growth molecules linked to cancer
8. VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells
9. Naturally occurring asbestos linked to lung cancer
10. Disappearing arctic lakes linked to climate change
11. Genes linked to treatment resistance in children with leukemia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
Breaking Biology Technology: